Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Goodwill (2019 - 2025)

Revolution Medicines has reported Goodwill over the past 7 years, most recently at $14.6 million for Q4 2025.

  • Quarterly results put Goodwill at $14.6 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $14.6 million (changed 0.0% YoY), and the annual figure for FY2025 was $14.6 million, changed 0.0%.
  • Goodwill for Q4 2025 was $14.6 million at Revolution Medicines, roughly flat from $14.6 million in the prior quarter.
  • Over the last five years, Goodwill for RVMD hit a ceiling of $14.6 million in Q1 2021 and a floor of $14.6 million in Q1 2021.
  • Median Goodwill over the past 5 years was $14.6 million (2021), compared with a mean of $14.6 million.
  • Peak annual rise in Goodwill hit 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Revolution Medicines' Goodwill stood at $14.6 million in 2021, then changed by 0.0% to $14.6 million in 2022, then changed by 0.0% to $14.6 million in 2023, then changed by 0.0% to $14.6 million in 2024, then changed by 0.0% to $14.6 million in 2025.
  • The last three reported values for Goodwill were $14.6 million (Q4 2025), $14.6 million (Q3 2025), and $14.6 million (Q2 2025) per Business Quant data.